A high rate of point mutations in TP53 is reported not only in childhood sarcomas and families with the Li-Fraumeni syndrome, but also in adult-onset sarcomas, including leiomyosarcoma, osteosarcoma, and undifferentiated pleomorphic sarcomas [10,11]. This evidence concerns the gene TP53 and osteosarcoma.